ClinicalTrials.govpublic full text
IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)
advanced or metastatic merkel cell carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 405157
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.